Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person7
Bluejay Diagnostics, Inc.
Company
Co-Diagnostics, Inc.
Company
Lucid Diagnostics Inc.
Company
QUEST DIAGNOSTICS INC
Company
Cardio Diagnostics Holdings, Inc.
Company
Insight Molecular Diagnostics Inc.
Company
SERA PROGNOSTICS, INC.
Company
Primary record12
Bluejay Diagnostics, Inc. filed 8-K
Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information regarding the Reverse Stock Split (as defined herein) contained in Item 5.03 of this Current
Bluejay Diagnostics, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 13, 2026, Bluejay Diagnostics, Inc. issued a press release regarding, among other things, the completion of certain manufacturing-related contractual obligations. The inform
Bluejay Diagnostics, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 6, 2026, Bluejay Diagnostics, Inc. issued a press release regarding baseline clinical characteristics from its SYMON-II clinical validation study. The information contained
Bluejay Diagnostics, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 1, 2026, Bluejay Diagnostics, Inc. (the Company ) entered into a Distribution, Co-Marketing & Strategic Partnership Agreement (the Distribution Agreement
Bluejay Diagnostics, Inc. filed 4
SEC form 4 filed by Bluejay Diagnostics, Inc. (CIK 1704287) on 2026-08-18.
Bluejay Diagnostics, Inc. filed 4
SEC form 4 filed by Bluejay Diagnostics, Inc. (CIK 1704287) on 2026-08-18.
Bluejay Diagnostics, Inc. filed 4
SEC form 4 filed by Bluejay Diagnostics, Inc. (CIK 1704287) on 2026-08-18.
Bluejay Diagnostics, Inc. filed 4
SEC form 4 filed by Bluejay Diagnostics, Inc. (CIK 1704287) on 2026-08-18.
Bluejay Diagnostics, Inc. filed 4
SEC form 4 filed by Bluejay Diagnostics, Inc. (CIK 1704287) on 2026-08-18.
ARMISTICE CAPITAL, LLC filed SCHEDULE 13G
0001172661-26-003556.txt : 20260814 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001601086 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 06/30/2026 0001704287 Bluejay Diagnostics, Inc. 095633608 360 Massa
Ayrton Capital LLC filed SCHEDULE 13G
0001493152-26-037644.txt : 20260813 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001698148 XXXXXXXX LIVE Common Stock 06/30/2026 0001704287 Bluejay Diagnostics, Inc. 095633608 360 Massachusetts Avenue Suite 203 Act
Bluejay Diagnostics, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On August 13, 2026, following the filing on August 12, 2026 of its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, Bluejay Diagnostics, Inc. issued a press re